Iron
Iron Deficiency Anemia
Cairo UniversitySmall moleculePhase 4 / ApprovedActive
BB
71/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 56/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Iron Deficiency Anemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ferric Cation Fundación para la Investigación del Hospital Clínico de Valencia | Phase 4 | A |
Iron Isomaltoside China-Japan Friendship Hospital | Phase 4 | BBB |
Iron(Ii) Sulphate (1:1), Heptahydrate Linda Malan | Phase 4 | BBB |
SODIUM FERRIC GLUCONATE Watson Pharmaceuticals | Phase 4 | BBB |
Iron Hydroxide Polymaltose Kaplan Medical Center | Phase 3 | BB |
View all 13 →
Same molecule, other indications
Iron is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →